Primary percutaneous coronary intervention and the role of thrombus aspiration
PhD ceremony: Ms. T. Svilaas, 14.45 uur, Academiegebouw, Broerstraat 5, Groningen
Title: Primary percutaneous coronary intervention and the role of thrombus aspiration
Promotor(s): prof. F. Zijlstra
Faculty: Medical Sciences
Removing a clot is better than angioplasty
After an acute hart attack, removing any clots (thrombus aspiration) is a better method than angioplasty. It reduces chances of patients dying within a year by nearly half, according to the research by Tone Svilaas.
Svilaas studied the effects of thrombus aspiration on 1071 patients who had suffered acute myocardial infarction. Half of the patients received standard angioplasty treatment while the other half were treated with thrombus aspiration. Svilaas concluded that thrombus aspiration led to good perfusion of the heart more often than angioplasty.
Of the patients treated with thrombus aspiration, 3.6 percent had died one year after treatment. The mortality rate in the control group was 6.7 percent. Those who underwent thrombus aspiration also had a much slighter chance of having a second heart attack.
Svilaas conducted her research together with colleagues from the departments of Cardiology and Pathology of the University Medical Center Groningen. She already published articles about the research in the renowned medical journals, The New England Journal of Medicine and The Lancet.
Acute myocardial infarction is the result of an atherosclerotic plaque (the result of ‘hardening’ of the arteries) tearing in a coronary artery. A clot (thrombus) is immediately formed where the plaque tears and this completely blocks the coronary artery. The part of the heart muscle that the artery provided with blood then dies due to lack of oxygen.
Angioplasty is the common treatment after a heart attack: a small balloon is used to widen the coronary artery and then a tube or stent is inserted. The thrombus itself is not removed. This does happen in thrombus aspiration, where the thrombus is sucked away through a thin tube. Completely removing the clot not only improves blood supply to the heart muscle but also prevents it from later coming loose and causing further damage to the artery further on.
Tone Svilaas (Norway, 1973) is training as a cardiologist at the Department of Cardiology of the UMCG Thorax Centre, which is also where conducted her PhD research.
Last modified: | 13 March 2020 01.14 a.m. |
More news
-
05 March 2025
Women in Science
The UG celebrates International Women’s Day with a special photo series: Women in Science.
-
28 February 2025
Vici grants for two UG/UMCG scientists
The Dutch Research Council (NWO) has awarded Vici grants, worth up to €1.5 million each, to Merel Keijzer and Charalampos Tsoumpas This will enable the researchers to develop an innovative line of research and set up their own research group for...
-
11 February 2025
Space for your disability
When it comes to collaborations between researchers from different faculties, the UG is at the top of its game. A prime example is the Disabled City project that researches how the mobility of people with a physical disability can be explored...